4DMedical Limited Stock
Stocks
4DX
AU0000095416
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
04:10:32 16/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 3.540 AUD | -5.35% |
|
+2.31% | -9.92% |
| 11:25am | Lotus Resources Most Shorted Stock on Australian Bourse, ASIC Data Shows | MT |
| 08/09 | ASX Biggest Losers | MT |
| Market Cap | 2.24B 1.6B 1.39B 1.31B 1.19B 2.23B 153B 15.63B 6.01B 77.79B 6.01B 5.87B 248B | P/E 2026 |
-151x | P/E 2027 * | -60.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.98B 1.41B 1.22B 1.16B 1.05B 1.96B 135B 13.79B 5.31B 68.62B 5.3B 5.18B 219B | EV / Sales 2026 |
344x | EV / Sales 2027 * | 88x |
| Free-Float |
93.93% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| 4DX | Delayed | |
OTC Markets
| FDMDF | Delayed | |
|
Deutsche Boerse AG
| MQ7 | Delayed | |
|
Tradegate
| MQ7 | Real-time | |
|
Boerse Muenchen
| MQ7 | Real-time |
Last Transcript: 4DMedical Limited
| 1 day | -5.35% | ||
| 1 week | +2.31% | ||
| Current month | +3.51% | ||
| 1 month | -4.58% | ||
| 3 months | -4.84% | ||
| 6 months | -7.57% | ||
| Current year | -9.92% |
| 1 week | 3.31 |  | 3.78 |
| 1 month | 3.31 | | 4.08 |
| Current year | 2.95 | | 7.55 |
| 1 year | 1.4 | | 7.55 |
| 3 years | 0.22 | | 7.55 |
| 5 years | 0.22 | | 7.55 |
| 10 years | 0.22 | | 7.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
CEO | Chief Executive Officer | - | 01/12/2012 |
Julian Sutton
DFI | Director of Finance/CFO | - | 02/01/2026 |
Greg Mogel
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
BRD | Director/Board Member | - | 01/12/2012 |
Lilian Bianchi
CHM | Chairman | - | 02/11/2023 |
John Livingston
BRD | Director/Board Member | - | 01/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/6/26 | Buy | Chief Financial Officer | 13,054 | 0.0022% | ||
| 4/3/26 | Exercice | Director | 213,464 | 0.0373% | ||
| 4/3/26 | Exercice | Director | 213,464 | 0.0373% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.35% | +2.31% | +102.87% | +485.12% | 1.6B | |
| +4.53% | +6.36% | +35.18% | +24.41% | 237B | |
| +3.01% | +2.01% | +11.04% | -17.98% | 147B | |
| -0.21% | +7.71% | -13.09% | +27.62% | 133B | |
| -2.62% | -2.47% | -56.07% | -17.07% | 63.58B | |
| -0.76% | -0.36% | -19.06% | -14.84% | 49.95B | |
| +0.26% | -1.13% | +12.74% | +17.13% | 49.42B | |
| +2.36% | +2.33% | +19.61% | +29.64% | 42.37B | |
| +1.73% | +3.52% | +39.48% | +51.23% | 40.98B | |
| +2.89% | +3.80% | -15.40% | +57.81% | 32.82B | |
| Average | +0.42% | +0.37% | +11.73% | +64.31% | 79.83B | |
| Weighted average by Cap. | +1.67% | +2.42% | +8.07% | +14.87% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 8.34M 5.95M 5.15M 4.87M 4.41M 8.28M 571M 58.14M 22.37M 289M 22.34M 21.85M 923M | 22.8M 16.26M 14.08M 13.32M 12.06M 22.63M 1.56B 159M 61.15M 791M 61.08M 59.72M 2.52B |
| Net income | -177M -126M -109M -103M -93.63M -176M -12.11B -1.23B -475M -6.14B -474M -464M -19.59B | -38.5M -27.46M -23.78M -22.49M -20.36M -38.21M -2.63B -268M -103M -1.34B -103M -101M -4.26B |
| Net Debt | -264M -189M -163M -154M -140M -262M -18.09B -1.84B -709M -9.17B -708M -693M -29.26B | -236M -168M -146M -138M -125M -234M -16.16B -1.65B -633M -8.19B -633M -619M -26.13B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/09/26 | $3.540 | -5.35% | 2,932,965 |
| 15/09/26 | $3.740 | +8.72% | 5,370,439 |
| 14/09/26 | $3.440 | +2.38% | 2,729,441 |
| 11/09/26 | $3.360 | -3.45% | 2,768,381 |
| 10/09/26 | $3.480 | +0.58% | 1,543,114 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4DX Stock
Select your edition
All financial news and data tailored to specific country editions
